The role of selected NKG2DLs such as MICA, MICB and ULBP4 as potential markers in multiple sclerosis

Abstract The interaction between natural killer group 2 members D and their ligands (NKG2D-NKG2DLs) may play a role in the immunopathology of multiple sclerosis (MS). Owing to their measurable presence in biofluids, soluble NKG2DLs may serve as potential biomarkers for disease activity. NKG2DL famil...

Full description

Bibliographic Details
Published in:	Scientific Reports
Main Authors:	Aleksandra Pogoda-Wesołowska, Agata Świątek, Agnieszka Synowiec, Robert Zdanowski, Ignacy Stachura, Aneta Szewczuk, Ewelina Pietras, Adam Stępień
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-07-01
Subjects:	Multiple sclerosis Natural killer cells NKG2D NKG2DLs Biomarkers Neurofilament light chains
Online Access:	https://doi.org/10.1038/s41598-025-12589-0

Similar Items

The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
by: Ana Stojanovic, et al.
Published: (2018-04-01)

INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN
by: E. V. Abakushina, et al.
Published: (2017-01-01)

KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP
by: Reem Alkhayer, et al.
Published: (2023-05-01)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
by: Tobias Zöller, et al.
Published: (2018-03-01)

Downregulation of NKG2DLs by TGF-β in human lung cancer cells
by: Young Shin Lee, et al.
Published: (2021-07-01)

The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
by: Florencia Secchiari, et al.
Published: (2022-12-01)

MICA-specific nanobodies for diagnosis and immunotherapy of MICA+ tumors
by: Elisha R. Verhaar, et al.
Published: (2024-03-01)

Stress-induced MICA and MICB molecules in oncology
by: S. A. Yurevna, et al.
Published: (2022-07-01)

Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma
by: Yaping Long, et al.
Published: (2018-09-01)

Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
by: Thornton W Thompson, et al.
Published: (2017-12-01)

The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-01-01)

CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
by: Xin Jin, et al.
Published: (2023-12-01)

Ectopic ULBP2 Is Associated with Decreased NKG2D Expression in CD8<sup>+</sup> T Cells Under T Cell-Modulatory Conditions in a Murine Tumor Model
by: Yasuhiko Teruya, et al.
Published: (2025-06-01)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
by: Ge Tan, et al.
Published: (2023-08-01)

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
by: Jagoda Siemaszko, et al.
Published: (2021-06-01)

Exploring the dynamic of NKG2D/NKG2DL axis: A central regulator of NK cell functions
by: Caterina Marangio, et al.
Published: (2025-05-01)

A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer
by: Elitsa Boneva, et al.
Published: (2025-03-01)

Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease
by: Daniel Fernández-Soto, et al.
Published: (2024-02-01)

NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
by: Alessandra Zingoni, et al.
Published: (2020-03-01)

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
by: Fabrizio Antonangeli, et al.
Published: (2017-11-01)

Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular Carcinoma
by: Shirin Tavakoli, et al.
Published: (2024-12-01)

NKG2D and Its Ligands: “One for All, All for One”
by: Alessandra Zingoni, et al.
Published: (2018-03-01)

MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma
by: Alessandra Zingoni, et al.
Published: (2018-05-01)

MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells
by: Hitoshi Toyoda, et al.
Published: (2024-10-01)

Editorial: Emerging Concepts on the NKG2D Receptor-Ligand Axis in Health and Diseases
by: Nadia Guerra, et al.
Published: (2020-04-01)

Preclinical characterization of Pan-NKG2D ligand-binding NKG2D receptor decoys
by: Peter B. Rupert, et al.
Published: (2024-04-01)

MICA and NKG2D gene polymorphisms influence graft survival, and response to therapy in kidney transplantation
by: Roberto Littera, et al.
Published: (2024-11-01)

The impact of Glycosyl-Phosphatidyl-Inositol anchored MICA alleles on novel NKG2D-based therapies
by: Mar eVales-Gomez
Published: (2015-04-01)

Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
by: Tristan Courau, et al.
Published: (2019-03-01)

Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands
by: Daniel Fallon, et al.
Published: (2024-12-01)

Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response
by: Stipan eJonjic
Published: (2011-12-01)

Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells
by: Jagoda Siemaszko, et al.
Published: (2023-10-01)

A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression
by: Trever T Greene, et al.
Published: (2016-11-01)

Impact of NKG2D Signaling on Natural Killer and T‐Cell Function in Cerebral Ischemia
by: Christina David, et al.
Published: (2023-06-01)

Untargeted Metabolomics Showed Accumulation of One-Carbon Metabolites to Facilitate DNA Methylation during Extracellular Matrix Detachment of Cancer Cells
by: Suza Mohammad Nur, et al.
Published: (2022-03-01)

Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle‐associated MICA: Dual role in cancer immunosurveillance
by: Elisabetta Vulpis, et al.
Published: (2022-01-01)

Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response
by: Adeline Raynaud, et al.
Published: (2021-01-01)

Shared epitope and polymorphism of MICA and NKG2D encoding genes in Greek and Polish patients with rheumatoid arthritis
by: Joanna Wielińska, et al.
Published: (2021-03-01)

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
by: Jack G. Fisher, et al.
Published: (2022-11-01)

Two major human phenotypes of MICA molecules and their differential activation to NK cells via NKG2D receptor
by: Qizhi Luo, et al.
Published: (2025-05-01)